Nuclear translocation of nuclear transcription factor-κB by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons

被引:33
作者
de Erausquin, GA
Hyrc, K
Dorsey, DA
Mamah, D
Dokucu, M
Mascó, DH
Walton, T
Dikranian, K
Soriano, M
Verdugo, JMG
Goldberg, MP
Dugan, LL
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA
[4] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Farmacol, RA-5000 Cordoba, Argentina
[5] Univ Valencia, Dept Biol Celular, Valencia, Spain
关键词
D O I
10.1124/mol.63.4.784
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We describe a new molecular mechanism of cell death by excitotoxicity mediated through nuclear transcription factor kappaB (NFkappaB) in rat embryonic cultures of dopaminergic neurons. Treatment of mesencephalic cultures with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) resulted in a number of changes that occurred selectively in dopaminergic neurons, including persistent elevation in intracellular Ca2+ monitored with Fura-2, and a significant increase in intramitochondrial oxidation of dihydrorhodamine 123, probably associated with transient increase of mitochondrial permeability, cytochrome c release, nuclear translocation of NFkappaB, and transcriptional activation of the oncogene p53. Interruption of any of these steps by specific antagonists prevented neurite pruning and programmed cell death. In contrast, cell death was not prevented by caspase antagonists and only partly prevented by nitric-oxide synthase inhibitors. This signal transduction pathway might. be a contributing mechanism in ongoing neuronal death in Parkinson disease.
引用
收藏
页码:784 / 790
页数:7
相关论文
共 41 条
  • [1] Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
  • [2] Calcineurin and mitochondrial function in glutamate-induced neuronal cell death
    Ankarcrona, M
    Dypbukt, JM
    Orrenius, S
    Nicotera, P
    [J]. FEBS LETTERS, 1996, 394 (03): : 321 - 324
  • [3] Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices
    Bywood, PT
    Johnson, SM
    [J]. EXPERIMENTAL NEUROLOGY, 2000, 162 (01) : 180 - 188
  • [4] Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-κB in cellular models of Parkinson's disease
    Cassarino, DS
    Halvorsen, EM
    Swerdlow, RH
    Abramova, NN
    Parker, WD
    Sturgill, TW
    Bennett, JP
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) : 1384 - 1392
  • [5] Chen SH, 2000, GLIA, V31, P249, DOI 10.1002/1098-1136(200009)31:3<249::AID-GLIA60>3.0.CO
  • [6] 2-L
  • [7] Chung KC, 2000, J NEUROSCI RES, V59, P117, DOI 10.1002/(SICI)1097-4547(20000101)59:1<117::AID-JNR14>3.3.CO
  • [8] 2-H
  • [9] The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
    Damier, P
    Hirsch, EC
    Agid, Y
    Graybiel, AM
    [J]. BRAIN, 1999, 122 : 1437 - 1448
  • [10] K+-EVOKED DOPAMINE RELEASE DEPENDS ON A CYTOSOLIC CA2+ POOL REGULATED BY N-TYPE CA2+ CHANNELS
    DEERAUSQUIN, G
    BROOKER, G
    HANBAUER, I
    [J]. NEUROSCIENCE LETTERS, 1992, 145 (02) : 121 - 125